Adrien Buisson

554 total citations
16 papers, 151 citations indexed

About

Adrien Buisson is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Adrien Buisson has authored 16 papers receiving a total of 151 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Adrien Buisson's work include BRCA gene mutations in cancer (7 papers), PARP inhibition in cancer therapy (7 papers) and DNA Repair Mechanisms (3 papers). Adrien Buisson is often cited by papers focused on BRCA gene mutations in cancer (7 papers), PARP inhibition in cancer therapy (7 papers) and DNA Repair Mechanisms (3 papers). Adrien Buisson collaborates with scholars based in France, Spain and Belgium. Adrien Buisson's co-authors include Olivier Trédan, Sophie Giraud, Sana Intidhar Labidi‐Galy, Julien Péron, Valeria Viassolo, Alexandre Bodmer, Valérie Bonadona, Pierre O. Chappuis, Alex Friedlaender and Isabelle Treilleux and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and The American Journal of Surgical Pathology.

In The Last Decade

Adrien Buisson

13 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrien Buisson France 6 94 73 56 38 34 16 151
Tereza Vaclová Spain 8 61 0.6× 132 1.8× 74 1.3× 40 1.1× 57 1.7× 12 205
Natalie R. Davidson United States 5 136 1.4× 137 1.9× 135 2.4× 73 1.9× 19 0.6× 16 297
Mahbubl Ahmed United Kingdom 6 70 0.7× 128 1.8× 86 1.5× 73 1.9× 56 1.6× 13 232
Munemasa Nagao Japan 7 79 0.8× 143 2.0× 66 1.2× 37 1.0× 13 0.4× 13 211
R. D. Kennedy United States 3 91 1.0× 108 1.5× 51 0.9× 62 1.6× 53 1.6× 5 192
Lisanne E. Nijman Netherlands 5 68 0.7× 60 0.8× 29 0.5× 63 1.7× 18 0.5× 13 156
Eric J. Schafer United States 3 55 0.6× 124 1.7× 34 0.6× 40 1.1× 43 1.3× 4 187
Elodie Noël United Kingdom 6 57 0.6× 139 1.9× 26 0.5× 47 1.2× 37 1.1× 6 203
Joyce Solomons United Kingdom 6 169 1.8× 160 2.2× 47 0.8× 17 0.4× 24 0.7× 7 225
Kavitta Sivanandan Malaysia 4 76 0.8× 149 2.0× 66 1.2× 53 1.4× 20 0.6× 4 201

Countries citing papers authored by Adrien Buisson

Since Specialization
Citations

This map shows the geographic impact of Adrien Buisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrien Buisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrien Buisson more than expected).

Fields of papers citing papers by Adrien Buisson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrien Buisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrien Buisson. The network helps show where Adrien Buisson may publish in the future.

Co-authorship network of co-authors of Adrien Buisson

This figure shows the co-authorship network connecting the top 25 collaborators of Adrien Buisson. A scholar is included among the top collaborators of Adrien Buisson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrien Buisson. Adrien Buisson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Collet, L., Pierre Méeus, Nicolás Chopin, et al.. (2023). Gynecological carcinosarcomas: Overview and future perspectives. Bulletin du Cancer. 110(11). 1215–1226.
2.
Buisson, Adrien, Pierre Saintigny, Pantelis Constantoulakis, et al.. (2023). Blinded-assessment of a solution to evaluate olaparib maintenance treatment efficacy in patients with ovarian cancer from the GINECO/ENGOT PAOLA-1 trial.. Journal of Clinical Oncology. 41(16_suppl). 5588–5588.
3.
Bouras, Ahmed, Mélanie Léoné, Adrien Buisson, et al.. (2023). Overview of the Genetic Causes of Hereditary Breast and Ovarian Cancer Syndrome in a Large French Patient Cohort. Cancers. 15(13). 3420–3420. 3 indexed citations
5.
Buisson, Adrien, Pierre Saintigny, Éric Pujade-Lauraine, et al.. (2022). A deep learning solution for detection of homologous recombination deficiency in ovarian cancer using low pass whole-genome sequencing: Evaluation of the analytical performance.. Journal of Clinical Oncology. 40(16_suppl). e17599–e17599. 7 indexed citations
6.
Fouchardière, Arnaud de la, et al.. (2022). Attempting to Solve the Pigmented Epithelioid Melanocytoma (PEM) Conundrum. The American Journal of Surgical Pathology. 46(8). 1106–1115. 12 indexed citations
8.
Swalduz, Aurélie, et al.. (2021). Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report. JTO Clinical and Research Reports. 2(6). 100192–100192. 7 indexed citations
9.
Coutzac, Clélia, Matthieu Sarabi, Françoise Desseigne, et al.. (2021). Hyperprogressive Disease After Combined Anti-PD-L1 and Anti-CTLA-4 Immunotherapy for MSI-H/dMMR Gastric Cancer: A Case Report. Frontiers in Oncology. 11. 756365–756365. 2 indexed citations
10.
Cohen, Romain, Vincent Jonchère, Christelle de la Fouchardière, et al.. (2021). Adrenal gland as a sanctuary site for immunotherapy in patients with microsatellite instability-high metastatic colorectal cancer. Journal for ImmunoTherapy of Cancer. 9(2). e001903–e001903. 18 indexed citations
11.
Høberg‐Vetti, Hildegunn, Adrien Buisson, Sarah Ariansen, et al.. (2020). The intronic BRCA1 c.5407-25T>A variant causing partly skipping of exon 23—a likely pathogenic variant with reduced penetrance?. European Journal of Human Genetics. 28(8). 1078–1086. 5 indexed citations
12.
Péron, Julien, Alex Friedlaender, Valeria Viassolo, et al.. (2020). Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes. Scientific Reports. 10(1). 7073–7073. 72 indexed citations
13.
Buisson, Adrien, et al.. (2019). Compound blue nevus: a reappraisal of the concept in the genomic era. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 476(3). 439–443. 5 indexed citations
14.
Friedlaender, Alex, Valeria Viassolo, Jean‐Damien Combes, et al.. (2019). BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. Breast Cancer Research and Treatment. 174(3). 775–783. 15 indexed citations
15.
Pons, Linda, Patrice Bouvagnet, Sylvie Di Filippo, et al.. (2019). Supravalvular Aortic Stenosis Caused by a Familial Chromosome 7 Inversion Disrupting the ELN Gene Uncovered by Whole-Genome Sequencing. Molecular Syndromology. 10(4). 209–213. 2 indexed citations
16.
Labidi‐Galy, Sana Intidhar, Thibault De La Motte Rouge, Olfa Derbel, et al.. (2018). Predictive factors for prolonged response to olaparib as maintenance therapy in ovarian cancer patients with BRCA mutations.. Journal of Clinical Oncology. 36(15_suppl). 5558–5558. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026